These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12566593)

  • 41. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
    Pieruccini-Faria F; Jones JA; Almeida QJ
    Neuroscience; 2016 Mar; 318():219-29. PubMed ID: 26794593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Motor response to repeated dopaminergic stimulation in Parkinson's disease.
    Obeso JA; Luquin MR; Grandas F; Vaamonde J; Laguna J; Martinez-Lage JM
    Clin Neuropharmacol; 1992 Feb; 15(1):75-9. PubMed ID: 1349508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of some dopamine agents on modulation of memory processes performance in rats.
    Rusu G; Nechifor M; Lupusoru CE; Tartau L
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):959-64. PubMed ID: 24502076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease.
    Schubert T; Volkmann J; Müller U; Sturm V; Voges J; Freund HJ; Von Cramon DY
    Exp Brain Res; 2002 May; 144(1):8-16. PubMed ID: 11976755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits.
    Holthoff VA; Vieregge P; Kessler J; Pietrzyk U; Herholz K; Bönner J; Wagner R; Wienhard K; Pawlik G; Heiss WD
    Ann Neurol; 1994 Aug; 36(2):176-82. PubMed ID: 8053653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spatial and object working memory deficits in Parkinson's disease are due to impairment in different underlying processes.
    Possin KL; Filoteo JV; Song DD; Salmon DP
    Neuropsychology; 2008 Sep; 22(5):585-95. PubMed ID: 18763878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.
    Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M
    Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N30 wave of somatosensory evoked potentials in Parkinson's disease: a pharmacological approach.
    Traversa R; Pierantozzi M; Semprini R; Loberti M; Peppe A; Cicardi MC; Stanzione P
    Electroencephalogr Clin Neurophysiol Suppl; 1996; 46():193-200. PubMed ID: 9059793
    [No Abstract]   [Full Text] [Related]  

  • 52. [Age-related working memory decline in patients with Parkinson's disease].
    Tamura I; Kikuchi S; Kitagawa M; Otsuki M; Tashiro K
    No To Shinkei; 2003 Apr; 55(4):335-40. PubMed ID: 12755037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractionating the Neurocognitive Mechanisms Underlying Working Memory: Independent Effects of Dopamine and Parkinson's Disease.
    Fallon SJ; Mattiesing RM; Muhammed K; Manohar S; Husain M
    Cereb Cortex; 2017 Dec; 27(12):5727-5738. PubMed ID: 29040416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease.
    van Wouwe NC; Kanoff KE; Claassen DO; Spears CA; Neimat J; van den Wildenberg WP; Wylie SA
    J Cogn Neurosci; 2016 May; 28(5):710-23. PubMed ID: 26836515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic modulation of the default mode network in Parkinson's disease.
    Delaveau P; Salgado-Pineda P; Fossati P; Witjas T; Azulay JP; Blin O
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):784-92. PubMed ID: 20674286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
    Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
    Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.